Nemours among Delaware health care providers preparing to approve COVID vaccine for children


COVID vaccines for children ages 5-11 are coming in the next few weeks – and Delaware Children’s Hospital is preparing.

Children have not yet been able to receive a COVID-19 vaccine.

The FDA is reviewing a vaccine for children ages 5-11 this week and is expected to be approved shortly. The vaccine was approved by an FDA advisory body on Tuesday and must now be approved by the FDA and CDC before healthcare providers can begin firing shots.

Framework from President Biden For the introduction of vaccines for children, it is necessary to rely on pediatricians and children’s hospitals.

In Delaware, Nemours Children’s Health is preparing to launch the modified vaccine through its post-approval pediatricians and hospital. The head of the Primary Care Division, Dr. Jonathan Miller says they have relied on primary care physicians for some time to promote vaccinations.

“It’s easy to get this early wave of people vaccinated because they are motivated to do so,” he says. “But the people who aren’t particularly interested in the vaccine, if we can take them to their pediatrician, there’s a good chance the pediatrician can help them make that decision about vaccinating their child.”

Miller says vaccinating children should be even less of a worry than vaccinating adults. They often experience fewer vaccine side effects than adults, and the benefits of vaccination far outweigh the possible long-term effects of contracting COVID-19.

He says easing school restrictions will be a big reason to convince parents to vaccinate their children.

“And the truth is, we all want to go back to some normalcy,” says Miller. “As if I wanted to send my 6-year-old to school one day without a mask – but that will never be possible until we have vaccinated a critical mass of this age group. And so I can’t wait the next few weeks before I can vaccinate my daughter. “

Miller estimates that most school restrictions are unlikely to be lifted this school year, but if vaccination rates are high enough, they could go away next September.

The Pizer vaccine is currently being reviewed by the FDA for use in children, though Moderna recently released data That supports the use of his vaccine between the ages of 6 and 11.

Miller says children should expect to receive the same two dose series given to those 12 and older.

“The vaccination rate is the same for adults and children, but the dose is different,” he says. “So all people who are going to vaccinate 5-11 have to stock up on a different product with a different vaccine and be ready to use that.”

Miller says the amount of vaccine used in children is about a third of the amount given to children 12 and older.

Roman Battaglia is a member of the corps Report for America, a national service program that places journalists in local newsrooms.


About Author

Leave A Reply